Tandem Diabetes Care's GAAP loss for 3 months of 2022 was $14.715 million, up 2.92 times from $5.044 million in the previous year. Revenue increased 24.7% to $175.907 million from $141.037 million a year earlier.
Tandem Diabetes Care's GAAP loss for 3 months of 2022 was $14.715 million, up 2.92 times from $5.044 million in the previous year. Revenue increased 24.7% to $175.907 million from $141.037 million a year earlier. 
investor.tandemdiabetes.com
English (US) 